Clinical Trial Update: Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients [Phase 3]

View source ↗

Summary

Phase 3 long-term follow-up study evaluating durability of sustained virologic response in alisporivir-treated Hepatitis C patients; results were posted in Augu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Alisporivir (alisporivir)

Snippet

Sponsor: Debiopharm International SA | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2016-08-26